Sign In
Buy ABT
$90.51
-0.0200 (-0.0221%)
At Close: Jun 24, 2026
ZBH or ABT: Which Is the Better Value Stock Right Now?
12:47pm, Wednesday, 25'th Oct 2023
Investors looking for stocks in the Medical - Products sector might want to consider either Zimmer Biomet (ZBH) or Abbott (ABT). But which of these two companies is the best option for those looking f
5 Stocks to Watch on Solid Revenues in Last Reported Quarter
09:48am, Wednesday, 25'th Oct 2023
We have narrowed our search to five U.S. corporate behemoths. These are: JPM, UNH, PG, ABT, FCX.
Are These 3 Dividend Aristocrats Undervalued Hidden Gems?
06:30am, Wednesday, 25'th Oct 2023
If you look at MarketBeat's list of dividend aristocrats, you'll see a select group of publicly traded companies that have an outstanding track record of consistently increasing their dividend payouts
Abbott Laboratories May Soon Launch a Game-Changing New Device in the U.S.
10:01am, Tuesday, 24'th Oct 2023
Abbott Laboratories' business has underwhelmed investors in 2023, as testing numbers are down big. Growth in its medical devices was the only bright spot in the company's recent earnings report.
Here is What to Know Beyond Why Abbott Laboratories (ABT) is a Trending Stock
10:33am, Monday, 23'rd Oct 2023
Recently, Zacks.com users have been paying close attention to Abbott (ABT). This makes it worthwhile to examine what the stock has in store.
The Value Deepens for Medtech Stocks: Reversal Imminent
10:21am, Monday, 23'rd Oct 2023
Results from Johnson & Johnson NYSE: JNJ and Abbott Laboratories NYSE: ABT foreshadow good news for MedTech investors. Both companies outperformed on the top and bottom lines, driven by broad strength
Abbott Labs: Fear Is In The Air - That's Why I'm Bullish
04:30pm, Friday, 20'th Oct 2023
Abbott Laboratories reported solid growth across all segments in its third-quarter results, excluding its COVID diagnostics portfolio. The company's medical devices business, which includes its Diabet
7 Blue-Chip Stocks to Buy on the Dip
02:48pm, Thursday, 19'th Oct 2023
While there are many ways to position yourself in the market during this ambiguous juncture, one of the most straightforward approaches involves targeting blue-chip stocks to buy on the dip. By defini
Abbott Earnings Show Obesity Drug Worries Are Overblown
11:56am, Thursday, 19'th Oct 2023
CEO Robert Ford said more users of its glucose monitoring system were using the device while also taking new obesity drugs.
'We don't see' weight-loss drugs impacting medical devices' sales, says Abbott CEO Robert Ford
06:07pm, Wednesday, 18'th Oct 2023
Robert Ford, Abbott chairman and CEO, joins 'Closing Bell Overtime' to talk Q3 earnings, the impact of weight loss drugs on their product and more.
Abbott (ABT) Q3 Earnings and Revenues Surpass, Margins Dip
12:03pm, Wednesday, 18'th Oct 2023
Abbott (ABT) reports solid underlying base business performance in the third quarter of 2023.
Geopolitical Conflicts in Middle-East in Focus
12:02pm, Wednesday, 18'th Oct 2023
Geopolitical Conflicts in Middle-East in Focus.
Abbott Laboratories 3Q earnings top estimates on strong medical devices sales growth
10:47am, Wednesday, 18'th Oct 2023
Abbott Laboratories (NYSE:ABT) shares rose after the healthcare technology company posted a third quarter earnings beat and provided strong full-year guidance. While revenue decreased 2.8% year-over-y
Abbott (ABT) Beats Q3 Earnings and Revenue Estimates
10:32am, Wednesday, 18'th Oct 2023
Abbott (ABT) came out with quarterly earnings of $1.14 per share, beating the Zacks Consensus Estimate of $1.10 per share. This compares to earnings of $1.15 per share a year ago.
Oversold and Overextended, Abbott Laboratories is a Great Buy
09:16am, Wednesday, 18'th Oct 2023
Abbott Laboratories NYSE: ABT share price has trended lower for nearly 2 years, but that trend is over. The impact of COVID on sales and the post-COVID letdown were cause enough for the market to sell
